Elsevier Launches Publishing Ethics Resource Kit

Online resource to support journal editors handling publishing ethics issues

Amsterdam, March 04, 2008 – Elsevier, the world-leading publisher of scientific, technical and medical information products and services, announced today the launch of its Publishing Ethics Resource Kit (PERK).

Launching PERK at the Elsevier Editors’ Conference in Singapore, Mark Seeley, Senior Vice President and General Legal Counsel, described PERK as being “a single point of access for information and guidelines on publishing ethics providing our Journal Editors with the support they need in dealing with issues of publishing ethics.”

PERK is an online resource which contains links to Elsevier and non-Elsevier policy and procedures documents, decision trees and flow charts for dealing with different forms of publishing ethics abuse with the recommended action that can be followed, as well as COPE ( Committee On Publication Ethics) charts for a second opinion. It also contains examples of appropriate letters for various situations and a large resource of useful information structured in the form of Questions and Answers.

As part of our commitment to the protection and enhancement of the peer-review process, we have a responsibility to assist the scientific community in all aspects of publishing ethics” says Martin Tanke, Managing Director S&T Journal Publishing. “In the past months we have been the first major scientific publisher to commit to full membership for all its publications in COPE and we are one of six scientific publishers participating in the CrossRef Association’s pilot plagiarism software called CrossCheck. By launching the Publishing Ethics Resource Kit as well, we improve our efforts even more to meet this responsibility”.

# # #

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contacts:
Federica Rosetta
Elsevier
+31 20 485 3359